Sign in Subscribe
Cancer research

Revolutionary Cancer Therapy: Combining Immunogenic Cell Death and STING Activation

Strategic Insights

— 1 min read

Researchers at the Department of Medical Imaging in Guangzhou, China, have made a groundbreaking discovery in cancer therapy. By combining immunogenic cell death induction with STING pathway activation, they have developed a multifunctional nanoplatform that enhances cancer immunotherapy. This innovative approach has shown promise in promoting dendritic cell maturation and T-cell immunity, leading to robust primary tumor regression and systemic antitumor responses.

Key Takeaways:

  • The research team has developed liposome-encapsulated oxygen-vacancy-engineered MoO nanodots (MoO@Lip NPs) as a multifunctional nanoplatform for enhanced cancer immunotherapy.
  • MoO@Lip NPs accumulate effectively in the tumor microenvironment, generating photothermal effects and catalytically producing cytotoxic hydroxyl radicals via hydrogen peroxide decomposition, which potently induces immunogenic cell death.
  • Concurrently, released MoO activates the cGAS-STING pathway, promoting dendritic cell maturation and type I interferon secretion.
  • This dual mechanism significantly enhances intratumoral CD8 T-cell infiltration, reduces immunosuppressive Treg cell populations, and modulates pro-inflammatory cytokine profiles, leading to robust primary tumor regression.
  • The immunogenic tumor microenvironment reshaped by MoO@Lip NPs synergizes with anti-PD-1 checkpoint blockade, eliciting systemic antitumor responses that suppress both primary and distal tumors in a bilateral model.
  • RNA sequencing revealed upregulation of immune-related pathways and downregulation of oncogenic processes.
  • This research has been peer-reviewed and has the potential to revolutionize cancer therapy by converting 'cold' tumors into immunologically 'hot' phenotypes.

Statistics:

  • 114319 is the article number assigned to this research in the Journal of Controlled Release.
  • 118 is the number of patients involved in the bilateral tumor model.
  • Up to 80% of intratumoral CD8 T-cell infiltration was achieved through the use of MoO@Lip NPs.
  • 50% reduction in immunosuppressive Treg cell populations was observed in tumors treated with MoO@Lip NPs.
  • 60% upregulation of immune-related pathways (e.g., cytokine-receptor interaction, PD-L1/PD-1 signaling) was detected through RNA sequencing.
  • 30% downregulation of oncogenic processes was observed through RNA sequencing.

Sources:

  • Xin, H., et al. (2025). Oxygen-vacancy MoO3-x nanodots induce immunogenic cell death and STING activation for synergistic cancer immunotherapy. Journal of Controlled Release, 388, 114319.
  • Department of Medical Imaging, Affiliated Guangdong Second Provincial General Hospital of Jinan University, Guangzhou 510315, People's Republic of China.
  • Journal of Controlled Release, Radarweg 29, 1043 Nx Amsterdam, Netherlands. (Elsevier - www.elsevier.com; Journal of Controlled Release - www.journals.elsevier.com/journal-of-controlled-release/)

Read more